Ringpu Bio-Technology redirects IPO funds for biomanufacturing industrialization project

Tianjin Ringpu Bio-Technology announced on October 24, 2025, that it will establish and alter dedicated fundraising accounts to support the "Biomanufacturing Industrialization Project." This change, approved by the board of directors and supervisory board, involves opening a new account at Bohai Bank and changing the purpose of existing accounts at Ping An Bank and China Construction Bank. The former purpose of these accounts, related to "South China Biological Large-scale Suspension Culture Workshop Project" and "Zhong'an Biological Expansion Project," will now be dedicated to the "Biomanufacturing Industrialization Project."

The company's board has authorized the chairman and delegated personnel to manage these account changes, including signing tripartite supervision agreements. This move follows the approval of a proposal to change the use of certain raised funds during the fifth board meeting on October 24, 2025, and the fifth ad-hoc shareholders' meeting of 2025. The total net proceeds from the 2021 offering were 1,322,020,470.39 yuan.

The company's third-quarter report for 2025 indicated a 13.50% increase in operating revenue to 2,544,325,031.33 yuan and a 45.64% rise in net profit attributable to shareholders to 362,307,052.90 yuan. These financial results underscore the company's robust performance amid its strategic adjustments in fund allocation for future growth.